PUT - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 11:35:43 17/05/2024 pm IST | ||
| 4.36 EUR | +2.35% |
|
| Current month | -46.50% | ||
| 1 month | -51.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 4.36 | +2.35% |
| 16/24/16 | 4.26 | +7.30% |
| 15/24/15 | 3.97 | -17.81% |
| 14/24/14 | 4.83 | -4.92% |
| 13/24/13 | 5.08 | +7.17% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 11:35 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM7ZA2 |
| ISIN | DE000VM7ZA24 |
| Date issued | 04/01/2024 |
| Strike | 359.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.75 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.35 € |
|---|---|
| Lowest since issue | 3.38 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
